 MedPage Today | Clinical Context – Multiple Sclerosis MedPage Today Treatment with the monoclonal antibody daclizumab (Zenapax) resulted in significant decreases in contrast-enhancing lesions on MRI in patients with multiple sclerosis (MS), a small, open-label study found. ... |
